The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000527.5(LDLR):c.298G>A (p.Asp100Asn)

CA10584832

251121 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 2a5e70a7-3328-461c-97ec-ad2a36bcd68d
Approved on: 2023-04-28
Published on: 2023-05-01

HGVS expressions

NM_000527.5:c.298G>A
NM_000527.5(LDLR):c.298G>A (p.Asp100Asn)
NC_000019.10:g.11102771G>A
CM000681.2:g.11102771G>A
NC_000019.9:g.11213447G>A
CM000681.1:g.11213447G>A
NC_000019.8:g.11074447G>A
NG_009060.1:g.18391G>A
ENST00000558518.6:c.298G>A
ENST00000252444.9:n.552G>A
ENST00000455727.6:c.298G>A
ENST00000535915.5:c.190+2426G>A
ENST00000545707.5:c.298G>A
ENST00000557933.5:c.298G>A
ENST00000557958.1:n.384G>A
ENST00000558013.5:c.298G>A
ENST00000558518.5:c.298G>A
NM_000527.4:c.298G>A
NM_001195798.1:c.298G>A
NM_001195799.1:c.190+2426G>A
NM_001195800.1:c.298G>A
NM_001195803.1:c.298G>A
NM_001195798.2:c.298G>A
NM_001195799.2:c.190+2426G>A
NM_001195800.2:c.298G>A
NM_001195803.2:c.298G>A

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 6
PP1 PP4 PP3 PM3 PS4_Supporting PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.298G>A (p.Asp100Asn) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying evidence codes PM2, PM3, PP1, PP3, PP4, PS4_supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: - PM2: This variant is absent from gnomAD (gnomAD v2.1.1) - PM3: Variant meets PM2 and is identified in an index case with homozygous FH phenotype (LDL-C=10.25 mmol/L ) as homozygous status, from PMID: 25936346. - PP1: Variant segregates with FH phenotype in at least 2 informative meiosis from 1 family from PMID: 25936346 - PP3: REVEL = 0.93 - PP4: Variant meets PM2 and is identified in at least 1 index case who fulfills SB possible FH from Ambry Genetics, after alternative causes for high cholesterol were excluded. - PS4_supporting: Variant meets PM2 and is identified in 2 index cases (1 case with Simon-Broome criteria of possible FH from Ambry Genetics, 1 cases with Simon-Broome criteria of possible FH from PMID: 25936346)
Met criteria codes
PP1
Variant segregates with FH phenotype in at least 2 informative meiosis from 1 family from PMID: 25936346
PP4
Variant meets PM2 and is identified in at least 1 index case who fulfills SB possible FH from Ambry Genetics, after alternative causes for high cholesterol were excluded.
PP3
REVEL = 0.93
PM3
Variant meets PM2 and is identified in an index case with homozygous FH phenotype (LDL-C=10.25 mmol/L ) as homozygous status, from PMID: 25936346.
PS4_Supporting
Variant meets PM2 and is identified in 2 index cases (1 case with Simon-Broome criteria of possible FH from Ambry Genetics, 1 cases with Simon-Broome criteria of possible FH from PMID: 25936346)
PM2
This variant is absent from gnomAD (gnomAD v2.1.1)
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.